Literature DB >> 9839820

A tetrodotoxin-resistant voltage-gated sodium channel from human dorsal root ganglia, hPN3/SCN10A.

Douglas K Rabert1, Bruce D Koch, Mariola Ilnicka, Rena A Obernolte, Susan L Naylor, Ronald C Herman, Richard M Eglen, John C Hunter, Lakshmi Sangameswaran.   

Abstract

Neuropathic pain may be produced, at least in part, by the increased activity of primary afferent neurons. Studies have suggested that an accumulation of voltage-gated sodium channels at the site of peripheral nerve injury is a primary precursory event for subsequent afferent hyperexcitability. In this study, a human sodium channel (hPN3, SCN10A) has been cloned from the lumbar 4/5 dorsal root ganglia (DRG). Expression of hPN3 in Xenopus oocytes showed that this clone is a functional voltage-gated sodium channel. The amino acid sequence of hPN3 is most closely related to the rat PN3/SNS sodium channels which are expressed primarily in the small neurons of rat DRGs. The homologous relationship between rPN3 and hPN3 is defined by (i) a high level of sequence identity (ii) sodium currents that are highly resistant to tetrodotoxin (TTX) (iii) similar tissue distribution profiles and (iv) orthologous chromosomal map positions. Since rPN3/SNS has been implicated in nociceptive transmission, hPN3 may prove to be a valuable target for therapeutic agents against neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9839820     DOI: 10.1016/S0304-3959(98)00120-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  23 in total

1.  Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic.

Authors:  Tao Yang; Thomas C Atack; Dina Myers Stroud; Wei Zhang; Lynn Hall; Dan M Roden
Journal:  Circ Res       Date:  2012-06-20       Impact factor: 17.367

2.  Repurposing the Dihydropyridine Calcium Channel Inhibitor Nicardipine as a Nav1.8 Inhibitor In Vivo for Pitt Hopkins Syndrome.

Authors:  Sean Ekins; Ana C Puhl; Audrey Davidow
Journal:  Pharm Res       Date:  2020-06-11       Impact factor: 4.200

3.  Several common variants modulate heart rate, PR interval and QRS duration.

Authors:  Hilma Holm; Daniel F Gudbjartsson; David O Arnar; Gudmar Thorleifsson; Gudmundur Thorgeirsson; Hrafnhildur Stefansdottir; Sigurjon A Gudjonsson; Aslaug Jonasdottir; Ellisiv B Mathiesen; Inger Njølstad; Audhild Nyrnes; Tom Wilsgaard; Erin M Hald; Kristian Hveem; Camilla Stoltenberg; Maja-Lisa Løchen; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

Review 4.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

5.  Regulation of Nav1.6 and Nav1.8 peripheral nerve Na+ channels by auxiliary β-subunits.

Authors:  Juan Zhao; Michael E O'Leary; Mohamed Chahine
Journal:  J Neurophysiol       Date:  2011-05-11       Impact factor: 2.714

6.  Intraperitoneal and intravenous lidocaine for effective pain relief after laparoscopic appendectomy: a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Tae Han Kim; Hyun Kang; Joon Hwa Hong; Jun Seok Park; Chong Wha Baek; Jin Yun Kim; Yong Hun Jung; Hyang Kyoung Kim
Journal:  Surg Endosc       Date:  2011-04-13       Impact factor: 4.584

7.  Structural determinants of drugs acting on the Nav1.8 channel.

Authors:  Liam E Browne; Frank E Blaney; Shahnaz P Yusaf; Jeff J Clare; Dennis Wray
Journal:  J Biol Chem       Date:  2009-02-19       Impact factor: 5.157

8.  Common Coding Variants in SCN10A Are Associated With the Nav1.8 Late Current and Cardiac Conduction.

Authors:  Vincenzo Macri; Jennifer A Brody; Dan E Arking; William J Hucker; Xiaoyan Yin; Honghuang Lin; Robert W Mills; Moritz F Sinner; Steven A Lubitz; Ching-Ti Liu; Alanna C Morrison; Alvaro Alonso; Ning Li; Vadim V Fedorov; Paul M Janssen; Joshua C Bis; Susan R Heckbert; Elena V Dolmatova; Thomas Lumley; Colleen M Sitlani; L Adrienne Cupples; Sara L Pulit; Christopher Newton-Cheh; John Barnard; Jonathan D Smith; David R Van Wagoner; Mina K Chung; Gus J Vlahakes; Christopher J O'Donnell; Jerome I Rotter; Kenneth B Margulies; Michael P Morley; Thomas P Cappola; Emelia J Benjamin; Donna Muzny; Richard A Gibbs; Rebecca D Jackson; Jared W Magnani; Caroline N Herndon; Stephen S Rich; Bruce M Psaty; David J Milan; Eric Boerwinkle; Peter J Mohler; Nona Sotoodehnia; Patrick T Ellinor
Journal:  Circ Genom Precis Med       Date:  2018-05

9.  Increased peripheral nerve excitability and local NaV1.8 mRNA up-regulation in painful neuropathy.

Authors:  Devang Kashyap Thakor; Audrey Lin; Yoshizo Matsuka; Edward M Meyer; Supanigar Ruangsri; Ichiro Nishimura; Igor Spigelman
Journal:  Mol Pain       Date:  2009-03-25       Impact factor: 3.395

10.  Genome-wide association study of PR interval.

Authors:  Arne Pfeufer; Charlotte van Noord; Kristin D Marciante; Dan E Arking; Martin G Larson; Albert Vernon Smith; Kirill V Tarasov; Martina Müller; Nona Sotoodehnia; Moritz F Sinner; Germaine C Verwoert; Man Li; W H Linda Kao; Anna Köttgen; Josef Coresh; Joshua C Bis; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Fernando Rivadeneira; Albert Hofman; Jan A Kors; Bruno H C Stricker; André G Uitterlinden; Cornelia M van Duijn; Britt M Beckmann; Wiebke Sauter; Christian Gieger; Steven A Lubitz; Christopher Newton-Cheh; Thomas J Wang; Jared W Magnani; Renate B Schnabel; Mina K Chung; John Barnard; Jonathan D Smith; David R Van Wagoner; Ramachandran S Vasan; Thor Aspelund; Gudny Eiriksdottir; Tamara B Harris; Lenore J Launer; Samer S Najjar; Edward Lakatta; David Schlessinger; Manuela Uda; Gonçalo R Abecasis; Bertram Müller-Myhsok; Georg B Ehret; Eric Boerwinkle; Aravinda Chakravarti; Elsayed Z Soliman; Kathryn L Lunetta; Siegfried Perz; H-Erich Wichmann; Thomas Meitinger; Daniel Levy; Vilmundur Gudnason; Patrick T Ellinor; Serena Sanna; Stefan Kääb; Jacqueline C M Witteman; Alvaro Alonso; Emelia J Benjamin; Susan R Heckbert
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.